"Breaking ground in hepatology at #APASL2024 in Kyoto! Joining forces for the 6th Consensus & 14th Annual Meeting to drive innovation and improve patient care. #LiverResearch
Identifying non-response to steroids early is crucial in autoimmune hepatitis causing acute-on-chronic liver failure. A study on 165 patients reveals that AARC score, MELD score, and dynamic SURFASA score on day 3 accurately predict non-response.
pubmed.ncbi.nlm.nih.gov/36790652/#:~:t…
Revolutionizing autoimmune hepatitis research! Our study unveils a game-changer: Identifying early non-response to steroids in AIH-ACLF with precision. Baseline AARC, MELD, and dynamic SURFASA scores on day 3 hold the key! #LiverHealthpubmed.ncbi.nlm.nih.gov/36790652/.
Exciting day at AARC VC in ILBS! 95+ investigators, including Dr. Rakhmetova Veneta from Astana Medical University, Kazakhstan, presenting an ACLF case. Also, Dr. Ashish Kumar from Ganga Ram Hospital showcasing another intriguing ACLF case. Stay tuned for insights and updates!
Join healthcare leaders worldwide at the 92nd AARC VC on Nov 24, 3:30 PM IST. Honoring champions, discussing critical ACLF cases with 95+ international centers. Your esteemed presence is vital. ✨ #AARC#GlobalHealthLeaders#HealthcareInnovation
#AASLD , a nexus of knowledge from Nov 10-14! At the 7-8 am AARC meeting on Nov 12, Prof. S. K Sarin senior professor department of hepatologist, ILBS, New Delhi. led a groundbreaking discussion on AARC's strengths and weaknesses, backed by a robust dataset of 10k+ patients.